Cabana Review

What Cabana charges

• NAD+: $169/mo — per month

It names the pharmacy and publishes its licensing gap

Its own words: "Our partner pharmacy is F&F Pharmacies Inc dba Jungle Jim's Pharmacy… They are licensed to dispense medications in 40 U.S. states."

It then names the ten it is not licensed in — California, Nevada, New Jersey, North Carolina, Texas, Massachusetts, Mississippi, New Hampshire, West Virginia and Delaware.

That is the pharmacy's licensure rather than the seller's own footprint, so no state list is recorded against Cabana itself and the exclusions are read as the pharmacy's.

It sells injectables and says its pharmacy does not compound sterile products

The catalogue includes an NAD+ injection, a semaglutide injection and a tirzepatide injection.

Its FAQ asks whether that named pharmacy offers sterile compounding services and answers: "No, the pharmacy does not dispense sterile compounds."

Both statements are on its own site and the site does not reconcile them. Neither is smoothed away here, and no explanation is supplied on the seller's behalf.

Only NAD+ has a price of its own

Its weight-loss floor covers three products at once — a semaglutide injection, a semaglutide tablet and a tirzepatide injection all sit under one starting figure — so nothing is filed for either molecule.

Its four product pages publish no price at all, which leaves the floor as the only weight-loss number on the site.

The NAD+ figure is the one scoped to a single product, and the site says what it covers: the monthly supply, an injection kit, a provider consultation and expedited shipping.

A testing claim, and two things it says are not covered

It writes that "each batch authenticated with Certificates of Analysis for potency and purity. All materials meet strict USP and cGMP standards." No certificate is reachable, so that is a claim about testing rather than evidence of it.

It excludes lab work twice: the membership fee covers neither the blood work its own providers may order nor the diagnosis visit.

On the legal category its wording is plain: "Compounded medications have not received approval from the U.S. Food and Drug Administration (FDA). The FDA does not evaluate or confirm the safety, effectiveness, or manufacturing standards of compounded products."

How we verified this

• Read the pharmacy statement and copied the ten excluded states from the seller's own sentence, then recorded them against the pharmacy rather than against the seller.
• Read the sterile-compounding answer beside the three injectable products the site sells, and recorded both without choosing between them.
• Confirmed the weight-loss figure sits over three products at once and filed it against neither molecule, and confirmed its four product pages carry no price.
• Requested a deliberately meaningless address on this host in the same session and confirmed it returns a not-found response.
• Screened the brand, its trading name and its clinical group against the live federal warning-letter table, pulling all 3,677 records in pages and filtering locally because the table's own search parameter is ignored, through a matcher that normalises both the query and the filed company name before comparing, with a positive and a nonsense control in the same run; its named pharmacy was screened the same way.